Laboratory and telecom network technology group BATM Advanced Communications Ltd (LON:BVC) said a maiden profit in its biomedical arm had driven it back into the black.
BATM said the biomedical division, which makes up 54% of BATM's sales, had become profitable for the first time in the group's history.
The division's gross margin improved to 25% versus 23% in 2014, its distribution business expanded in absolute terms in all markets and its diagnostics unit reached break-even.
The group made a US$700,000 adjusted operating profit in the year to December 31 against a US$1mln loss a year ago.
BATM's telecom division started showing recovery as it reported a US$300,000 operating profit in the second half against a US$900,000 loss last time.
New products and technologies also continued to increase sales and replace legacy products, positioning the group to further improve revenues and gross margins.
Group pre-tax earnings before interest, depreciation and amortisation were US$2.5mln against US900,000mln a year ago.
Constant currency revenue rose to US$111.7mln from US$109.2mln beforehand.
Chief executive Zvi Marom said: "We believe we have turned a corner and transformed the group in both our divisions.
"Looking ahead, we entered 2016 in a stronger position, with a higher backlog, than at the same time in the prior year. We expect to maintain the momentum of last year."